Low versus standard dose mCPP challenge in obsessive-compulsive patients.
about
The age of anxiety: role of animal models of anxiolytic action in drug discovery.Assessing the validity of current mouse genetic models of obsessive-compulsive disorder.Updated overview of the putative role of the serotoninergic system in obsessive-compulsive disorderTrazodone: properties and utility in multiple disorders.
P2860
Low versus standard dose mCPP challenge in obsessive-compulsive patients.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh
2001年學術文章
@zh-hant
name
Low versus standard dose mCPP challenge in obsessive-compulsive patients.
@en
type
label
Low versus standard dose mCPP challenge in obsessive-compulsive patients.
@en
prefLabel
Low versus standard dose mCPP challenge in obsessive-compulsive patients.
@en
P2093
P1476
Low versus standard dose mCPP challenge in obsessive-compulsive patients
@en
P2093
P356
10.1016/S0893-133X(00)00178-0
P407
P577
2001-01-01T00:00:00Z
P6179
1036817685